community.elabeln.com/experiments.php?mode=edit&id=314
#314 Pharmacology Complete

IC50: ERK1 kinase + inhibitor X (ADP-Glo, 10 pt)

Started on
Tags
IC50 dose-response ERK1-kinase ADP-Glo lead-optimization
Custom ID

This template captures a 10-point dose-response IC50 determination of inhibitor X against recombinant ERK1 (MAPK3) kinase using the Promega ADP-Glo luminescent kinase assay in 384-well format, performed for lead-optimization compound profiling.

Goal: determine inhibitor X potency (IC50) against ERK1 with a Hill slope and Z’-factor confirming clean assay behavior, supporting SAR analysis for the inhibitor series targeting the MAPK signaling pathway.

Method overview: 10-point 3-fold serial dilution of inhibitor X from 10 µM to 0.5 nM in DMSO, then diluted 100-fold into kinase reaction buffer for 1% final DMSO. Recombinant ERK1 at 5 nM final, MBP substrate at 1 µM final, ATP at 50 µM (apparent Km), 25 mM HEPES pH 7.4, 10 mM MgCl₂, 1 mM DTT, 0.01% Tween-20. 5 µL kinase + inhibitor pre-incubation (15 min RT), 5 µL substrate + ATP start, 60-minute reaction at RT. 10 µL ADP-Glo Reagent quench + 30-min ADP→ATP conversion, 20 µL Kinase Detection Reagent, 60-min luminescence development, read on Synergy Neo2 luminometer.

Expected: Inhibitor X IC50 of 280 ± 40 nM (consistent with prior ERK1 screening for this scaffold), Hill slope between 1.0 and 2.0 (single-site behavior), Z’-factor > 0.5 (assay window robust), R² > 0.99 for 4PL fit. Reference inhibitor (SCH772984) IC50 within 2-fold of published 5 nM (assay validity control).

Last saved: 34 seconds ago
13 fields loaded from IC50 ADP-Glo Kinase baseline (SOP v1.2)
Target
Target
text
ERK1 (MAPK3)
Target conc
number
5nM
Substrate
text
MBP (myelin basic protein)
ATP conc
number
50µM (Km app)
Compound & Dose
Compound
text
Inhibitor X (compound ID INH-2026-0341)
High dose
number
10µM
Dilution factor
number
3
Dose points
number
10
Replicates
number
4
Curve Fit & QC
IC50
number
280nM
Hill slope
number
1.4
Z′-factor
number
0.86
number
0.997
compound_plate_map.pdf
198 KB
luminescence_raw.csv
24 KB
ic50_4PL_prism.xlsx
108 KB
01
Thaw compound stock + reference inhibitor SCH772984 from -80 °C
On dry ice, brief vortex
0:10
02
Prepare 10-point 3-fold dilution series in DMSO (10 mM → 0.5 µM source)
Source plate D1
0:15
03
Echo-dispense 50 nL per well of 384-well assay plate (4 reps × 10 doses + ctrls)
Echo 550 acoustic
0:08
04
Dispense 5 µL kinase mix (10 nM ERK1 in 1× buffer) per well; pre-incubate 15 min RT
0:15
05
Dispense 5 µL substrate + ATP mix (2 µM MBP + 100 µM ATP) per well; start kinase reaction
0:05
06
Incubate 60 min at RT (kinase reaction)
1:00
07
Dispense 10 µL ADP-Glo Reagent per well; incubate 40 min RT (ADP→ATP)
0:42
08
Dispense 20 µL Kinase Detection Reagent per well; incubate 60 min RT (luciferase)
1:02
09
Read luminescence on Synergy Neo2 (10 s integration per well); export raw CSV
BioTek run 2026-0604-1432
0:08
10
4PL fit in GraphPad Prism, extract IC50 + Hill + Z' + R²; archive workbook
IC50 280 nM · slope 1.4 · Z' 0.86 · R² 0.997
0:20
A B C D E F G
1 Dose (nM) Rep 1 Rep 2 Rep 3 Rep 4 Mean RLU % Activity
2 10000 12,841 12,503 13,108 12,772 12,806 5
3 3333 15,124 14,891 15,308 15,142 15,116 9
4 1111 23,008 22,891 23,401 23,099 23,100 18
5 370 57,221 58,109 56,892 57,944 57,541 49
6 123 90,418 91,287 89,914 90,872 90,623 78
7 41 105,891 106,442 104,981 106,182 105,874 90
8 14 112,109 111,541 113,008 112,494 112,288 95
9 4.5 115,442 114,892 116,201 115,109 115,411 98
10 1.5 116,108 115,872 116,991 116,341 116,328 99
11 0.5 116,418 115,991 116,712 116,108 116,307 99
12 DMSO ctrl 117,108 116,872 117,341 116,994 117,079 100
13 no kinase 8,109 7,891 8,341 8,108 8,112 0
Recombinant ERK1 (MAPK3), active
#PV3311 · Lot 2562842
In stock
MBP substrate (myelin basic protein)
#M1891 · Lot SLBS9421A
In stock
ATP (10 mM working stock)
in-house · Lot 2026-04
In stock
ADP-Glo Reagent
#V6930 · Lot 0000456871
In stock
Kinase Detection Reagent
#V6930 · Lot 0000456871
In stock
SCH772984 (reference ERK1/2 inhibitor)
#S7101 · Lot SLBT1284
Low
Compound source plate (DMSO master)
-80 °C · Compound Mgmt Freezer C-4 · Box CMP-2026-Q2
×1
ERK1 kinase aliquots (10 µL working)
-80 °C · Freezer A-1 · Drawer 2 · Box ENZ-KIN-2026
×24
ADP-Glo reagents (working aliquots)
-20 °C · Freezer A-1 · Drawer 3 · Box ADP-GLO-WK
×6
Visibility
Discovery BiologyK. Patel
Can write
K. PatelDr. R. Singh




Use Ctrl + click to add text